Overview
Murat Serilmez practices practicing medicine in Fatih, Turkey.
His clinical expertise encompasses Lung Cancer, EGFR Positive Lung Cancer, Ovarian Cancer, and Liver Cancer.
He is actively involved in clinical research, co-authoring 39 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Murat Serilmez
Is Murat Serilmez a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Murat Serilmez is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Murat Serilmez participate in research or clinical trials?
Yes. Murat Serilmez has published 39 articles and abstracts on conditions like Lung Cancer. You can view a list of Murat Serilmez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMr. Serilmez isExperienced. Learn about EGFR Positive Lung Cancer.
- Liver CancerMr. Serilmez isExperienced. Learn about Liver Cancer.
- Lung CancerMr. Serilmez isExperienced. Learn about Lung Cancer.
- Ovarian CancerMr. Serilmez isExperienced. Learn about Ovarian Cancer.